MSLN is expressed on the membrane of mesothelial cells of the peritoneal and pleural cavities, and overexpression of MSLN has been observed in mesothelioma, ovarian, lung, oesophageal, endometrial and breast cancers [75]. Here, MSLN is linked to mesothelioma.